BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 12, 2005
View Archived Issues
Mechanisms underlying SERP-1 mediated inhibition of monocytic adhesion and migration
Read More
Preclinical efficacy of GRN-163 in lung cancer
Read More
Liposomal encapsulation improves dexamethasone's profile
Read More
Novel highly potent and selective TACE inhibitor disclosed
Read More
Tesaglitazar reduces the incidence of metabolic syndrome in hypertriglyceridemic patients
Read More
Avalon submits IND for AVN-944 for cancer
Read More
Anturol begins phase II study for overactive bladder syndrome
Read More
Intrac changes name to Javelin Pharmaceuticals
Read More
IPdR enters phase I cancer study
Read More
GlaxoSmithKline to acquire ID Biomedical
Read More
IND approved for clinical testing of Elacyt for cancer
Read More
Ardana holds pre-IND meeting for Teverelix LA
Read More
Xcytrin studied for second-line treatment of recurrent metastatic NSCLC
Read More
CE Mark approval for Taxus Liberte stent
Read More
BMS-740808: A novel factor Xa inhibitor with in vivo efficacy and good PK profile
Read More
Lateral hypothalamus orexin neurons: new targets for addiction
Read More
Exubera recommended for approval
Read More
Novel SARMs developed by Bristol-Myers Squibb
Read More
New therapeutic agents for cancer disclosed in recent patents
Read More
KSP inhibitor blocks tumor growth in mice
Read More
Update on darifenacin in overactive bladder
Read More
New data on the antiarrhythmic activity of AZD-7009
Read More
Astellas Pharma discloses novel therapeutic agents for bone disorders
Read More
Sorafenib submitted for European approval for advanced kidney cancer
Read More
FDA advisory committee votes to recommend Pargluva for type 2 diabetes
Read More
Biovail receives FDA approval for once-daily tramadol
Read More
New agents for treating hepatitis C infection disclosed by Japan Tobacco
Read More
Immunosuppressant S1P1 receptor agonists prepared and tested at Merck & Co.
Read More